Holen Sie sich die Stockscreener-App
16.73
4.04%
0.65
Handel nachbörslich:
17.05
0.32
+1.91%
Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten
CRBPCorbus Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference - GlobeNewswire
Corbus Pharmaceuticals to Present at Evercore HealthCONx Conference in December | CRBP Stock News - StockTitan
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Corbus Pharmaceuticals director sets plan for stock sale - Investing.com India
(CRBP) Investment Report - Stock Traders Daily
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Update - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
OrbiMed Advisors LLC Acquires New Stake in Corbus Pharmaceuticals Holdings Inc - GuruFocus.com
TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Corbus Pharmac - GuruFocus.com
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference - GlobeNewswire
Corbus Pharmaceuticals to Present at Jefferies London Healthcare Conference | CRBP Stock News - StockTitan
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Brokers Set Expectations for CRBP Q1 Earnings - MarketBeat
Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates - TipRanks
Corbus Pharmaceuticals: Q3 Earnings Snapshot - CT Insider
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire
Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
(CRBP) On The My Stocks Page - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Corbus Pharmaceuti - GuruFocus.com
Corbus Pharmaceuticals' (CRBP) Outperform Rating Reaffirmed at Wedbush - MarketBeat
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024 - The Manila Times
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $65.86 Consensus PT from Analysts - Defense World
Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Grows By 5.8% - MarketBeat
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $65.86 Consensus Price Target from Brokerages - MarketBeat
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - The Manila Times
Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch
Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock? - Inkl
Up 174% In 2024, Is It Too Late To Buy This Breakout Biotech Stock? - Barchart
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat
Oppenheimer maintains steady target on Corbus Pharmaceuticals By Investing.com - Investing.com UK
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):